Kiromic BioPharma Inc: Falls nearly 2% in Nasdaq debut

Kiromic Biopharma

16/10/2020 17:11

** Gene-editing company's shares  KRBP.O  down nearly 2% in
Nasdaq debut
    ** Stock opens at $11.8, giving KRBP a market valuation of
more than $85.4 mln
    ** Earlier on Thursday, KRBP priced its IPO at $12/shr,
raising $15 mln  urn:newsml:reuters.com:*:nBw3sJ8VGa
    ** Co had previously priced its IPO between $12 and $14 per
share 
    ** ThinkEquitY is acting as sole book-running manager for
the offering
    

 (Reporting by Madhvi Pokhriyal in Bengaluru)
 ((Madhvi.pokhriyal@thomsonreuters.com))